Lymphoma (cont.)
Medical Author:
Jerry R. Balentine, DO, FACEP
Jerry R. Balentine, DO, FACEPDr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident. Medical Editor:
Melissa Conrad Stöppler, MD, Chief Medical Editor
Melissa Conrad Stöppler, MD, Chief Medical EditorMelissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology. IN THIS ARTICLE
Lymphoma Prevention and PrognosisThere is no known way to prevent lymphoma. A standard recommendation is to avoid the known risk factors for the disease. However, some risk factors for lymphoma are unknown, and therefore impossible to avoid. Infection with viruses such as HIV, EBV, and hepatitis are risk factors that can be avoided with frequent hand washing, practicing safe sex, and by not sharing needles, razors, toothbrushes, and similar personal items that might be contaminated with infected blood or secretions. The outlook for HL is very good. It is one of the most curable cancers. The five-year survival rate after treatment is greater than 80% for adults and greater than 90% for children. As a result of refinements in and more aggressive approaches to therapy, the outlook for NHL has improved significantly in the last few decades. The five-year survival rate after treatment is 63% for adults and up to 90% for children. The addition of immunotherapy to standard treatment for NHLs may further improve survival rates. Many people live with lymphoma in remission for many years after treatment. Next Page: Must Read Articles Related to Lymphoma
Bone Marrow Biopsy
A bone marrow biopsy is performed to evaluate bone marrow function or to determine the cause of some infections, diagnose tumors, determine how far a disease, s...learn more >>
Cancer Symptoms
Most symptoms and signs of cancer may also be explained by harmless conditions, so it's important to limit one's risk factors and undergo appropriate cancer scr...learn more >>
Cancer: What You Need to Know
The news comes like a sledgehammer into the stomach: "I'm sorry to tell you, but you have cancer." Every year, a million Americans are devastated by news of can...learn more >>
Viewer Comments & ReviewsLymphoma - SymptomsThe eMedicineHealth physician editors ask:Lymphoma symptoms can vary greatly from patient to patient. What were your symptoms at the onset of your disease? Lymphoma - Effective TreatmentThe eMedicineHealth physician editors ask:What treatment has been effective for your lymphoma? |
Women's Health
Find out what women really need.
From WebMD
Cancer Resources
Featured Centers
Health Solutions From Our Sponsors
Read What Your Physician is Reading on Medscape
Lymphoma, B-Cell »
Non-Hodgkin lymphoma (NHL) is a heterogenous group of lymphoproliferative malignancies with differing patterns of behavior and responses to treatment (Armitage, 1993).
Featured Topics
Medical Dictionary
Pill Identifier on RxList
- quick, easy,
pill identification
Find a Local Pharmacy
- including 24 hour, pharmacies




